肝硬化衰弱患者的高住院率及危险因素:一项为期10年的人群队列研究
该研究利用美国芝加哥地区7个医疗系统2011至2021年的电子健康记录数据,回顾性分析36,971例肝硬化患者的住院率及危险因素。结果显示,失代偿期肝硬化患者住院率最高,达每年每100人77.3次住院;与低衰弱患者相比,中度衰弱和重度衰弱的代偿期肝硬化患者年度住院的比值比分别为3.1(95%CI 2.9-3.4)和5.2(95%CI 4.5-6.0)。
要点
- 失代偿期肝硬化患者住院率最高,达每年每100人77.3次住院。
- 代偿期肝硬化合并中度衰弱患者年度住院OR为3.1(95%CI 2.9-3.4)。
- 代偿期肝硬化合并重度衰弱患者年度住院OR为5.2(95%CI 4.5-6.0)。
核心结论
- 代偿期和失代偿期肝硬化合并中度至重度衰弱的患者,与低衰弱患者相比,年度住院的比值显著增加。
- 未来工作应聚焦于将常规衰弱筛查纳入肝硬化诊疗的针对性干预,以最终降低高住院率。
研究设计与样本
- 回顾性纵向队列研究,使用芝加哥地区患者结果研究中心网络(CAPriCORN)数据库,该数据库汇集了芝加哥大都市区7个医疗系统2011至2021年去重后的电子健康记录数据。
- 共纳入36,971例肝硬化患者,其中16,265例(44%)曾住院(代偿期18.4%,失代偿期81.6%)。
- 主要结局为住院就诊率,衰弱采用医院衰弱风险评分定义,住院率以每年每100例患者报告,并采用多变量逻辑回归分析确定年度住院概率的预测因素。
主要发现
- 失代偿期肝硬化患者住院率最高,接近每年每100例患者77.3次住院。
- 代偿期肝硬化患者住院率也较高(14.2 vs 77.3次住院/100例患者/年)。
- 与低衰弱代偿期患者相比,中度衰弱代偿期患者年度住院的比值比为3.1(95%CI 2.9-3.4)。
- 与低衰弱代偿期患者相比,重度衰弱代偿期患者年度住院的比值比为5.2(95%CI 4.5-6.0)。
临床怎么用
- 作者建议未来工作应聚焦于将常规衰弱筛查纳入肝硬化诊疗的针对性干预,以最终降低高住院率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Cirrhosis-related inpatient hospitalizations have increased dramatically over the past decade. We used a longitudinal dataset capturing a large metropolitan area in the United States from 2011 to 2021 to evaluate contemporary hospitalization rates and risk factors among frail patients with cirrhosis. METHODS: We conducted a retrospective, longitudinal cohort study using the Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN) database, an electronic health record repository that aggregates de-duplicated data across 7 health care systems in the Chicago metropolitan area, from 2011 to 2021. The primary outcome of our study was the rate of hospitalization encounters. Frailty was defined by the Hospital Frailty Risk Score. Hospitalization rates were reported per 100 patients per year, and a multivariable logistic regression analysis identified predictors of annual hospitalization probability. RESULTS: During the study period, of 36,971 patients, 16,265 patients (44%) were hospitalized (compensated, 18.4%; decompensated, 81.6%). Hospitalization rates were highest in patients with decompensated cirrhosis, reaching nearly 77.3 hospitalizations/100 patients per year. Hospitalization rates among patients with compensated cirrhosis were also high (14.2 vs 77.3 hospitalization/100 patients per year), with odds of annual hospitalization 3 times (odds ratio, 3.1; 95% confidence interval, 2.9-3.4) as high among compensated patients with intermediate frailty and 5 times (odds ratio, 5.2; 95% confidence interval, 4.5-6.0) as high among those with severe frailty (compared with compensated patients with low frailty). CONCLUSION: Compensated and decompensated cirrhosis patients with intermediate to severe frailty face a substantially increased odds of annual hospitalizations compared with those with low frailty. Future work should focus on targeted interventions to incorporate routine frailty screenings into cirrhosis care and to ultimately minimize high hospitalization rates.
引用
- Hasjim BJ, Mohammadi M, Balbale SN, et al. High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study. Clin Gastroenterol Hepatol. 2024. PMID: 39426643. doi:10.1016/j.cgh.2024.08.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。